A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) for gemcitabine

Cheng Zhang,Ke Li,Shu-Ning Xu,Lei Qiao,Yu-Lin Ren,Qun Li,Ying Liu

DOI: https://doi.org/10.1080/14740338.2024.2419999

2024-10-26

Expert Opinion on Drug Safety

Abstract:Background Gemcitabine is widely used in the treatment of various cancers. This study aims to evaluate gemcitabine-associated adverse events (AEs) using the Food and Drug Administration Adverse Event Reporting System (FAERS) database.

pharmacology & pharmacy